Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 45175G207 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Biotechnology Value Fund L P
13G/A
Amendment 7
|
9.9% |
8/14/2026
Event 6/30/2026
|
|
| Biotechnology Value Fund L P | 5.4% | ||
| BVF I GP LLC | 5.4% | ||
| Biotechnology Value Fund II LP | 3.8% | ||
| BVF II GP LLC | 3.8% | ||
| Biotechnology Value Trading Fund OS LP | 0.6% | ||
| BVF Partners OS Ltd. | 0.6% | ||
| BVF GP Holdings LLC | 9.3% | ||
| BVF Partners L P/IL | 9.9% | ||
| BVF Inc/IL | 9.9% | ||
| Lampert Mark N | 9.9% | ||
|
Biotechnology Value Fund L P
13G/A
Amendment 6
|
9.9% |
5/15/2026
Event 3/31/2026
|
|
| Biotechnology Value Fund L P | 5.3% | ||
| BVF I GP LLC | 5.3% | ||
| Biotechnology Value Fund II LP | 3.9% | ||
| BVF II GP LLC | 3.9% | ||
| Biotechnology Value Trading Fund OS LP | 0.6% | ||
| BVF Partners OS Ltd. | 0.6% | ||
| BVF GP Holdings LLC | 9.2% | ||
| BVF Partners L P/IL | 9.9% | ||
| BVF Inc/IL | 9.9% | ||
| Lampert Mark N | 9.9% | ||
| Blue Owl Capital Holdings LP 13G/A Amendment 1 | 8.5% |
5/14/2026
Event 3/31/2026
|
|
|
Trails Edge Capital Partners, LP
13G
|
9.9% |
4/21/2026
Event 4/14/2026
|
|
| Trails Edge Capital Partners, LP | 9.9% | ||
| Trails Edge Biotechnology Master Fund, LP | 9.9% | ||
| Ortav Yehudai | 9.9% | ||
|
Omega Fund VI, L.P.
13D
|
8.4% |
4/21/2026
Event 4/14/2026
|
|
| Omega Fund VI, L.P. | 8.4% | ||
| Omega Fund VI GP, L.P. | 8.4% | ||
| Omega Fund VI GP Manager, Ltd. | 8.4% | ||
| Claudio Nessi | 8.4% | ||
| Otello Stampacchia | 8.4% | ||
|
Deep Track Capital, LP
13G/A
Amendment 1
|
0% |
2/13/2026
Event 12/31/2025
|
|
| Deep Track Capital, LP | 0% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 0% | ||
| David Kroin | 0% | ||
| Blue Owl Capital Holdings LP 13G | 7.4% |
2/12/2026
Event 12/31/2025
|
|
|
Funicular Funds, LP
13G
|
5.8% |
1/6/2026
Event 12/29/2025
|
|
| Funicular Funds, LP | 5.8% | ||
| Cable Car Capital, LP | 5.8% | ||
| Ma-Weaver Jacob | 5.8% | ||
| Blue Owl Capital Holdings LP 13G/A Amendment 1 | 4.8% |
11/14/2025
Event 9/30/2025
|
|
|
Biotechnology Value Fund L P
13G/A
Amendment 5
|
7.2% |
11/14/2025
Event 9/30/2025
|
|
| Biotechnology Value Fund L P | 3.7% | ||
| BVF I GP LLC | 3.7% | ||
| Biotechnology Value Fund II LP | 2.9% | ||
| BVF II GP LLC | 2.9% | ||
| Biotechnology Value Trading Fund OS LP | 0.4% | ||
| BVF Partners OS Ltd. | 0.4% | ||
| BVF GP Holdings LLC | 6.6% | ||
| BVF Partners L P/IL | 7.2% | ||
| BVF Inc/IL | 7.2% | ||
| Lampert Mark N | 7.2% | ||
|
Deep Track Capital, LP
13G
|
7.9% |
8/4/2025
Event 7/28/2025
|
|
| Deep Track Capital, LP | 7.9% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 7.9% | ||
| David Kroin | 7.9% | ||
|
Atlas Venture Fund X, L.P.
13D/A
Amendment 1
|
2.1% |
7/29/2025
Event 7/25/2025
|
|
| Atlas Venture Fund X, L.P. | 2.1% | ||
| Atlas Venture Associates X, L.P. | 2.1% | ||
| Atlas Venture Associates X, LLC | 2.1% | ||
| Atlas Venture Fund XI, L.P. | 0.9% | ||
| Atlas Venture Associates XI, L.P. | 0.9% | ||
| Atlas Venture Associates XI, LLC | 0.9% | ||
| Atlas Venture Opportunity Fund I, L.P. | 0.6% | ||
| Atlas Venture Associates Opportunity I, L.P. | 0.6% | ||
| Atlas Venture Associates Opportunity I, LLC | 0.6% | ||
|
BML Investment Partners, L.P.
13D/A
Amendment 1
|
1.9% |
7/28/2025
Event 7/25/2025
|
|
| BML Investment Partners, L.P. | 1.9% | ||
| Leonard Braden Michael | 1.9% |